GlassScriptPhysician profile
Xuebin Yin
NPI 1972548790
$3,345.14
in general payments reported to CMS, 2019-2025
18 companies · $446 in 2025
The $446 reported for 2025 was more than what 78% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $942 · 2020: $35.13 · 2021: $573 · 2022: $566 · 2023: $335 · 2024: $448 · 2025: $446.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,229.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,228.88 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,097.92 | 2019-2023 | Orilissa |
| Sumitomo Pharma America, INC. | $585.29 | 2023-2025 | Myfembree |
| Myovant Sciences INC. | $247.74 | 2021-2022 | |
| Millicent US INC | $181.94 | 2019-2020 | |
| Minerva Surgical, INC | $175.19 | 2025 | |
| Agile Therapeutics, INC. | $122.64 | 2023-2024 | Twirla |
| Lupin INC. | $121.24 | 2019 | |
| Amgen INC. | $118.73 | 2019 | |
| Mayne Pharma Commercial LLC | $118.03 | 2024 | |
| Pfizer INC. | $103.05 | 2019-2021 | |
| Foundation Medicine, INC. | $100.00 | 2022 | |
| Amag Pharmaceuticals, INC. | $95.49 | 2019 | |
| Exeltis, USA INC. | $88.40 | 2019-2025 | Slynd |
| Astellas Pharma US INC | $75.40 | 2025 | Veozah |
| Scynexis, INC. | $39.89 | 2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Coopersurgical, INC. | $38.40 | 2023-2024 | Paragard T 380a, Paragard T 380a |
| Hologic Sales and Service, LLC | $22.66 | 2024 | Aptima |
| Mission Pharmacal Company | $13.13 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Xuebin Yin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.